申请人:Norwich Eaton Pharmaceuticals, Inc.
公开号:EP0188107A2
公开(公告)日:1986-07-23
The invention involves a method of treating malignant tumors in a mammal with the compound ethyl 4-hydroxy-2-[15-morpholinomethyl-2-oxo)-3-oxazolidiny- liminomethyl]furo[2,3-b[pyridine-5-carboxylate (Compound 1) or its pharmaceutically acceptable salts or hydrates.
本发明涉及一种用化合物 4-羟基-2-[15-吗啉甲基-2-氧代)-3-噁唑烷-利氨基甲基]呋喃并[2,3-b]吡啶-5-羧酸乙酯(化合物 1)或其药学上可接受的盐或水合物治疗哺乳动物恶性肿瘤的方法。